Glomerular filtration rate (GFR) is a crucial parameter in post-transplant follow-up (PTF). CKD-EPI 2009 creatinine-based equation remains the most used estimated GFR (eGFR) and only few data are available on the other equations, based on creatinine, cystatin C or their combination. We evaluated 10 GFR estimation equations on 242 kidney-transplant recipient patients having measured GFR (mGFR) determination (urinary clearance of 99m Tc-DTPA) with simultaneous plasma enzymatic creatinine and serum cystatin C (immunoturbidimetry or immunonephelemetry) assessments. Five creatinine (MDRD 2006, CKD-EPI 2009 and 2021, EKFC 2021, KRS 2023), two cystatin C (CKD-EPI 2012, EKFC 2023) and three combined eGFR (CKD-EPI 2012 and 2021, combined EKFC) were evaluated. All equations were significantly correlated with mGFR (R² = 0.672–0.745) with a low median bias (+4.2 to −1.1 mL/min/1.73 m²). Chronic kidney disease staging agreements were all above 68% (maximum: 79.3% for CKD-EPI comb 2021). Percentages of eGFR comprised in between 30% of the mGFR ranged from 85.5% to 87.6% (combined equations), from 83.1% to 84.3% (cystatin C equations) and from 75.2% to 81.4% (creatinine equations). Combined creatinine/cystatin C eGFR equations with a P30 value greater to 85% of transplant recipients appeared closer to mGFR than cystatin C or creatinine eGFR.
Mondésert et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: